Independent medical education helping physicians acquire new clinical skills, test their knowledge, and improve their practice of medicine
Luxembourg, LU
Joined November 2019
- Tweets823
- Following797
- Followers333
- Likes118
When Less is More: Taking a Closer Look at Next-Generation Gadolinium-Based Contrast Agents in Contrast-Enhanced MRI. Get expert insights in this new streaming presentation. #PeerVoice #meded #radiology #MRI #CEMRI #GBCAs
peervoice.com/XDJ?PromoCode=…
Check out a new three-part activity on the trials driving innovation in #CKD and hear from experts on what makes eGFR-based endpoints clinically meaningful.
#PeerVoice #nephrology #chronickidneydisease
peervoice.com/ADH?PromoCode=…
ESMO time is coming up! The PeerVoice team is pleased to invite you to join our experts in Madrid for our dinner symposium on mCRPC.
Come visit our event website for registration and get the latest information from this event: peervoice.com/mCRPC-Madrid26
#ESMO26 #mCRPC #CME
Watch Now: peervoice.com/UJY?PromoCode=…
Where Change Begins: Why and How the Power of Primary Care Can Combat the Disruptive Symptoms of Menopause. Learn More in This New CE activity!
#PeerVoice #MedEd #CE #menopause #perimenopause #womenshealth
Join us tomorrow in Vienna for our Cutaneous Lupus Erythematosus CE-accredited Symposium at #EADVCongress!
⏱️ 12.30PM CET, meet us at 📍Hall E2 room and take part in this interactive session on #CLE with Drs Min, Wittmann and Figueras-Nart.
Lunch bags provided! #EADVEurope
Shifting the Status Quo in LS-SCLC: The Practicalities of Integrating Immunotherapy Into Treatment Pathways – Learn More in This New CME activity! @LauraAlderMD
peervoice.com/ZCX?PromoCode=…
#PeerVoice #MedEd #CME #oncology #radiationoncology #immunotherapy #SCLC
Thank you to Zosia Piotrowska, Aaron C. Tan & Jon Zugazagoitia for an outstanding #WCLC2026 symposium on #HER2-mutant #NSCLC and patient-centered care.
Missed it? On-demand coming soon: lnkd.in/d9KZ7CfS
#LungCancer #MedEd #CME #NSCLC
Tomorrow at #WCLC2026: Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia for a case-based discussion on selecting and sequencing therapy for advanced #HER2-mutant #NSCLC.
1:45-2:45 PM KST
Room 103, Grand Ballroom, 1F
lnkd.in/d9KZ7CfS
#NSCLC #lungcancer
Watch Now: peervoice.com/RAZ?PromoCode=…
Hear insights from Dr Eileen O’Reilly on how to overcome patient nihilism that accompanies a diagnosis of advanced #PancreaticCancer and an exciting update on novel treatments under investigation.
#PeerVoice #Oncology #Gastroenterology #CME
Stream a new 5-part #CE series of short episodes to hear about how comparative trials are shaping the current and future treatment landscape for #psoriaticarthritis
#PeerVoice #PsA #dermatology #rheumatology #MedicalEducation
peervoice.com/RRX?PromoCode=…
PeerVoice retweeted
Please join us for a virtual event on #HER2-directed therapies across #biliarytract, #colorectal, and #gastric cancers on @PeerVoice platform.
#BTC #CCA #GIcancers
@FLordick28391 #EricVanCutsem @HUNIMED @HumanitasMilano
Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2+ GI Cancers: Watch #CE replay to learn about the evolving role of HER2 as actionable biomarker!
peervoice.com/VPQ?PromoCode=…
#PeerVoice #meded #oncology #gastroenterology #GIcancers #mCRC #BTC #gastriccancer
Going to #WCLC2026 in Seoul? Do not miss the #PeerVoice industry symposium.
Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia, for a case-based discussion on selecting and sequencing systemic therapies for advanced #HER2-mutant #NSCLC.
lnkd.in/d9KZ7CfS
Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2+ GI Cancers: Watch #CE replay to learn about the evolving role of HER2 as actionable biomarker!
peervoice.com/VPQ?PromoCode=…
#PeerVoice #meded #oncology #gastroenterology #GIcancers #mCRC #BTC #gastriccancer
A Case-Based Masterclass Series: From Guidelines to Practice in the Management of #IgAN
#PeerVoice #MedEd #nephrology #CME #IgAN #nephropathy #glomerulardisease
peervoice.com/JQF?PromoCode=…
Strategies to Success in #IgAN Management: Harmonizing the Latest Evidence and Guidance to Maximize the Potential of Foundation Treatment Strategies
#PeerVoice #MedEd #nephrology #CME #IgAN #nephropathy #glomerulardisease
peervoice.com/NCD?PromoCode=…
PeerVoice retweeted
#ESOBlog about #FXIa inhibition & its potential role in secondary #stroke prevention.
Explore emerging evidence from OCEANIC-STROKE & discussions on balance between preventing recurrent stroke & bleeding risk.
A @PeerVoice activity, endorsed by ESO
👉 ow.ly/o51H50ZAKN0
Preparing to Turn Potential Into Progress in ES-SCLC: The Practicalities of DLL3-Targeted T-Cell Engagers. Get expert @g_mountzios insights in this new streaming presentation. #PeerVoice #meded #oncology #pulmonology #SCLC #ESSCLC peervoice.com/EMH?PromoCode=…
Watch Now: peervoice.com/KGV?PromoCode=…
Hear insights from clinicians and a patient on the burden of high-risk cutaneous squamous cell carcinoma, recent trial data, and the potential integration of systemic therapies
#PeerVoice #CSCC #oncology #otolaryngology #plasticsurgery #CE
Check out this #CE activity to hear insights from a clinician and a patient advocate on the burden of living with CIDP, its diagnostic and treatment challenges, and novel/emerging therapeutic strategies.
#PeerVoice #CIDP #neurology
peervoice.com/RZR?PromoCode=…
PeerVoice retweeted
In collaboration with @PeerVoice, ESO invites you to explore this free, on-demand, CE-accredited educational activity examining the potential of investigational Factor XIa inhibition for secondary #stroke prevention.
🎥 Watch now: ow.ly/LTzS50Zy5rv
#Neurology
